The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells
Open accessAbstract
Mature natural killer (NK) cells use Ca2+-dependent granule exocytosis and release of cytotoxic proteins, Fas ligand (FasL), and membrane-bound or secreted cytokines (tumor necrosis factor [TNF]-α) to induce target cell death. Fas belongs to the TNF receptor family of molecules, containing a conserved intracytoplasmic “death domain” that indirectly activates the caspase enzymatic cascade and ultimately apoptotic mechanisms in numerous cell types. Two additional members of this family, DR4 and DR5, transduce apoptotic signals upon binding soluble TNF-related apoptosis-inducing ligand (TRAIL) that, like FasL, belongs to the growing TNF family of molecules. Here, we report that TRAIL produced or expressed by different populations of primary human NK cells is functional, and represents a marker of differentiation or activation of these, and possibly other, cytotoxic leukocytes. During differentiation NK cells, sequentially and differentially, use distinct members of the TNF family or granule exocytosis to mediate target cell death. Phenotypically immature CD161+/CD56− NK cells mediate TRAIL-dependent but not FasL- or granule release–dependent cytotoxicity, whereas mature CD56+ NK cells mediate the latter two.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 839
Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., & Hood, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80400-8 · Cited by 711
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
Response of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
Self-citationIdentification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL
MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernandes-Alnemri, T., Cohen, G. M., & Alnemri, E. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25417 · Cited by 557
Self-citationTsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., & Kaneda, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3967 · Cited by 417
Perussia, B., Starr, S., Abraham, S., Fanning, V, & Trinchieri, G. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2133 · Cited by 409
Self-citationA nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., & Kriegler, M. (1990) · Cell · doi:10.1016/0092-8674(90)90158-b · Cited by 403
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
Stalder, T., Hahn, S., & Erb, P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1127 · Cited by 373
Cuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., & Trinchieri, G. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1581 · Cited by 360
Self-citationThomas, W. D., & Hersey, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2195 · Cited by 326
The Binding and Lysis of Target Cells by Cytotoxic Lymphocytes: Molecular and Cellular Aspects
Berke, G. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003511 · Cited by 305
Toksoz, D., Zsebo, K. M., Smith, K. A., Hu, S., Brankow, D., Suggs, S. V., Martin, F. H., & Williams, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7350 · Cited by 291
Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells
Oshimi, Y., Oda, S., Honda, Y., Nagata, S., & Miyazaki, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.2909 · Cited by 208
Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA
Marsters, S. A., Pitti, R. M., Donahue, C. J., Ruppert, S., Bauer, K. D., & Ashkenazi, A. (1996) · Current Biology · doi:10.1016/s0960-9822(09)00456-4 · Cited by 195
TCR/CD3 coupling to Fas-based cytotoxicity.
Vignaux, F., Vivier, E., Malissen, B., Depraetere, V, Nagata, S., & Golstein, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.781 · Cited by 187
Production of hematopoietic colony-stimulating factors by human natural killer cells.
Cuturi, M. C., Anegón, I., Sherman, F., Loudon, R., Clark, S. C., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.2.569 · Cited by 184
Self-citationPERUSSIA, B., Ramoni, C., Anegón, I., Cuturi, M. C., Faust, J. S., & Trinchieri, G. (1987) · PubMed · Cited by 181
Self-citationLee, R. K., Spielman, J., Zhao, D. Y., Olsen, K. J., & Podack, E. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1919 · Cited by 179
Fas Involvement in Cytotoxicity Mediated by Human NK Cells
Montel, A. H., Bochan, M. R., Hobbs, J. A., Lynch, D. H., & Brahmi, Z. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.9974 · Cited by 146
Bennett, I. M., Zatsepina, O. G., Zamai, L., Azzoni, L., Mikheeva, T., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1845 · Cited by 139
Self-citationRenard, V., Cambiaggi, A., Vely, F., Bléry, M., Olcese, L., Olivero, S., Bouchet, M., & Vivier, É. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00953.x · Cited by 119
Regulation of apoptosis and T cell activation by Fas-specific mAb
Alderson, M. R., Tough, T. W., Braddy, S. C., Davis-Smyth, T., Roux, E. R., Schooley, K., Miller, R. E., & Lynch, D. H. (1994) · International Immunology · doi:10.1093/intimm/6.11.1799 · Cited by 103
Chong, A. S., Scuderi, P., Grimes, W. J., & Hersh, E. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.2133 · Cited by 78
Mori, S., Jewett, A., Murakami-Mori, K., et al. (1997) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050384 · Cited by 65
CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95)
Thomas, W. D., & Hersey, P. (1998) · International Journal of Cancer · Cited by 54
Cited by
Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
Takeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051033 · Cited by 619
Metadata
- Authors
- Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., & Perussia, B.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-12-21
- Volume
- 188
- Issue
- 12
- Pages
- 2375-2380
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2140288892
- Cited by
- 566
- References
- 32
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.